Rethinking the Endpoints of mHealth Intervention Research in Diabetes Care

7Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mobile health (mHealth) is an emerging branch of medicine that utilizes technology to impact health care. With increasing access to smartphones and mobile devices, there has been an increase in both the availability and use of mHealth resources, including the use of text messages, apps, and web portals. In diabetes, there is particular interest as technology has long been a mainstay of management through glucometers, insulin pumps and continuous glucose monitors, which are increasingly interconnected. Although there is high demand for mHealth interventions in diabetes, there is no clear consensus on the best way to monitor these interventions. While randomized controlled trials are considered the gold standard for most medical research, we propose that alternative trial designs may be more applicable in the ever-changing mHealth landscape.

Cite

CITATION STYLE

APA

Modzelewski, K. L., Stockman, M. C., & Steenkamp, D. W. (2018). Rethinking the Endpoints of mHealth Intervention Research in Diabetes Care. Journal of Diabetes Science and Technology, 12(2), 389–392. https://doi.org/10.1177/1932296817733007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free